Hospitalization risks in the treatment of bipolar disorder: comparison of antipsychotic medications.

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Bipolar Disorders

• Publication date

  2007-05-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/J.1399-5618.2007.00394.XPMID 17430300
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Focus on Childhood and Adolescent Mental Health.

  2006cited by this paper
• The influence of study design on the results of pharmacoepidemiologic studies of diabetes risk with antipsychotic therapy.

  2006cited by this paper
• Treatment adherence among patients with bipolar or manic disorder taking atypical and typical antipsychotics.

  2006cited by this paper
• Prevalence and impact of comorbid anxiety and bipolar disorder.

  2006cited by this paper
• Diagnosis and management of patients with bipolar II disorder.

  2005cited by this paper
• Recognizing and managing bipolar disorder in children.

  2005cited by this paper
• Is it asthma or COPD?

  2005cited by this paper
• The many faces of bipolar disorder

  2005cited by this paper
• Screening for bipolar disorder in a primary care practice.

  2005cited by this paper
• Partial compliance and risk of rehospitalization among California Medicaid patients with schizophrenia.

  2004cited by this paper
• The many forms of bipolar disorder: a modern look at an old illness.

  2004cited by this paper
• Atypical antipsychotics and mood stabilization in bipolar disorder

  2003cited by this paper
• Atypical antipsychotics in first admission schizophrenia: medication continuation and outcomes.

  2003cited by this paper
• Unipolar mania over the course of a 20-year follow-up study.

  2003cited by this paper
• Rehospitalization Risk with Second-Generation and Depot Antipsychotics

  2003cited by this paper
• Practice guideline for the treatment of patients with bipolar disorder (revision).

  2002cited by this paper
• One-year rehospitalization rates of patients discharged on atypical versus conventional antipsychotics.

  2002cited by this paper
• Understanding those who seek frequent psychiatric hospitalizations.

  2002cited by this paper
• Extending indications for long-term pharmacotherapy: opportunities and challenges.

  2002cited by this paper
• Rehospitalization rates of chronically ill schizophrenic patients discharged on a regimen of risperidone, olanzapine, or conventional antipsychotics.

  2001cited by this paper
• Atypical antipsychotics in bipolar and schizoaffective disorders.

  2001cited by this paper
• From Clinical Trials to Real-World Practice: Use of Atypical Antipsychotic Medication Nationally in the Department of Veterans Affairs

  2001cited by this paper
• Rehospitalization rates of patients recently discharged on a regimen of risperidone or clozapine.

  1999cited by this paper
• Alcohol dependence and hospitalization in schizophrenia.

  1999cited by this paper
• Assessing clinical predictions of early rehospitalization in schizophrenia.

  1999cited by this paper
• Effectiveness of antipsychotic therapy in a naturalistic setting: a comparison between risperidone, perphenazine, and haloperidol.

  1999cited by this paper
• Long-term outcome of lithium prophylaxis in bipolar disorder: a 5-year prospective study of 402 patients at a lithium clinic.

  1998cited by this paper
• Predictors of Psychiatric Hospitalization: A Multivariate Analysis

  1998cited by this paper
• Novel Antipsychotics and Patient Care in State Hospitals

  1998cited by this paper
• Facilitating compliance with antipsychotic medication.

  1998cited by this paper
• Global mortality, disability, and the contribution of risk factors: Global Burden of Disease Study.

  1997cited by this paper
• Chronic neuroleptic exposure in bipolar outpatients.

  1997cited by this paper
• Factors influencing relapse in the long-term course of schizophrenia.

  1997cited by this paper
• Predicting readmission to the psychiatric hospital in a managed care environment: implications for quality indicators.

  1997cited by this paper
• Lithium use and discontinuation in a health maintenance organization.

  1996cited by this paper
• An economic evaluation of manic-depressive illness-1991

  1995cited by this paper
• The economic burden of affective disorders.

  1995cited by this paper
• Predicting the "revolving door" phenomenon among patients with schizophrenic, schizoaffective, and affective disorders.

  1995cited by this paper
• Course and outcome in bipolar affective disorder: a longitudinal follow-up study.

  1995cited by this paper
• The pharmacoeconomics of clozapine: a review.

  1994cited by this paper
• Lithium Prophylaxis in Recurrent Affective Illness

  1994cited by this paper
• Profile of a sample of subjects admitted to an acute care psychiatric facility with manic symptoms.

  1992cited by this paper
• Outcome in Mania. A 4-year prospective follow-up of 75 patients utilizing survival analysis.

  1990cited by this paper
• Gender differences of young adults with schizophrenic disorders in community care.

  1990cited by this paper
• Comparative efficacy of long-acting depot and oral neuroleptic medications in preventing schizophrenic recidivism.

  1987cited by this paper
• Comparative efficacy of long-acting depot and oral neuroleptic medications in preventing schizophrenic recidivism

  1987cited by this paper
• Misdiagnosis of schizophrenia in bipolar patients: a multiethnic comparison.

  1983cited by this paper

• Direct medical cost of bipolar disorder: Insights from the FACE-BD longitudinal cohort.

  2022cites this paper
• Predictors of 1-year rehospitalization in inpatients with bipolar I disorder treated with atypical antipsychotics

  2020cites this paper
• Combination Regimen With Lithium and Antipsychotic in Bipolar Manic Episodes: Impact on Adult Hospitalization Length of Stay

  2020cites this paper
• Hospitalization risk in bipolar disorder patients treated with lurasidone versus other atypical antipsychotics

  2019cites this paper
• Correlates of current rapid-cycling bipolar disorder: Results from the Italian multicentric RENDiBi study

  2019cites this paper
• Impact of once-daily extended-release quetiapine fumarate on hospitalization length in patients with acute bipolar mania.

  2015cites this paper
• Impact of extended-release quetiapine fumarate on hospitalization length and cost in schizophrenia and bipolar disorder patients: a retrospective, hospital-based, US-cohort analysis.

  2014cites this paper
• Correlates of psychiatric hospitalization in a clinical sample of Canadian adolescents with bipolar disorder.

  2014cites this paper
• Treatment patterns, healthcare resource utilization and costs in patients with bipolar disorder, newly treated with extended release or immediate release quetiapine fumarate using US healthcare administrative claims data.

  2013cites this paper
• Quetiapine: a pharmacoeconomic review of its use in bipolar disorder.

  2012cites this paper
• Role of Atypical Antipsychotics in Rapid Cycling Bipolar Disorder: A Review of the Literature

  2011cites this paper
• Dose trends for second-generation antipsychotic treatment of schizophrenia and bipolar disorder.

  2009cites this paper
• Current awareness in human psychopharmacology

  2008cites this paper